The 7th Annual MSK Symposium on Lymphoma features updated information on lymphoma biology, diagnosis, and ongoing efforts to translate scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes from world-renowned experts.

This year, the clinical management of the most frequent lymphoma entities are addressed and focused sessions related to new families of drugs being developed in these areas as well as in less common presentations are part of the program. Other highlights of this program include coverage of recent advances in the biology of lymphoma and how these will translate to innovative therapeutic interventions and panel discussions on how to best approach patients’ situations.

This on demand includes 15+ recorded lectures, along with select PDF versions of the speakers’ slides, from the live Symposium on May 5-6, 2023. Highlights of this on demand offering include:

• Access to both breakout sessions from the live Symposium: Science in Progress as well as the Nursing Professional Development
• Access to both the breakfast Symposium on Chronic Lymphocytic Leukemia as well as the luncheon session on What’s new in Multiple Myeloma
• A plenary lecture from Dr. Louis Staudt on Precision Medicine in Diffuse Large B-cell lymphoma
• Special sessions on Lymphoma Classifications, Interpreting Real Life Data, Late Effects of Therapy, and CAR T cells: Update on Eligibility and Toxicity

Brochure

https://mskcc.cloud-cme.com/Assets/mskcc/data/Lymphoma2023_Brochure.pdf